• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 41 of 100
FDA Sarepta Drug Approval Controversy
Newsletters
Does the FDA need to slow its drug approval roll?
By Sy MukherjeeJanuary 22, 2020
Medicine by machine: Is A.I. the cure for the world’s ailing drug industry?
Magazine
Medicine by machine: Is A.I. the cure for the world’s ailing drug industry?
By Jennifer AlseverJanuary 20, 2020
JPM 2020
Newsletters
Biopharma’s big week is upon us
By Sy MukherjeeJanuary 13, 2020
FDA Drug Approvals 2019
Newsletters
The FDA Kept Up Its Drug Approval Streak In 2019
By Sy MukherjeeJanuary 7, 2020
A heart graphic is seen displayed on an Apple Watch in this photo illustration in Warsaw, Poland on April 25, 2019.
Commentary
Pharma needs to stop chasing shiny objects and start embracing practical technology
By Paul HudsonJanuary 7, 2020
Big-Pharma-Prescription-Drugs
Health
Big Pharma Raised Prices of Several Prescription Drugs on First Day of 2020
By Chris MorrisJanuary 2, 2020
Sarepta Stock Roche Deal
Health
Controversial Biotech Sarepta Keeps Up Unlikely Win Streak With $1.15 Billion Roche Deal
By Sy MukherjeeDecember 23, 2019
Big Pharma ROI
Newsletters
Big Pharma’s Return on Investment Plummets to a Dismal 10-Year Low
By Sy MukherjeeDecember 18, 2019
Multiple myeloma MMRF
Newsletters
GlaxoSmithKline Hopes to Take on Rivals With Rare Blood Cancer Drug
By Sy MukherjeeDecember 17, 2019
Michigan Uses Drug Trafficking Law to Sue Walgreens and Other Opioid Distributors
Health
Michigan Uses Drug Trafficking Law to Sue Walgreens and Other Opioid Distributors
By David Eggert and The Associated PressDecember 17, 2019
Drugs and Tech Revolutionizinf Healthcare
Health
The 4 Most Game-Changing Medical Advances of the Past Decade
By Sy MukherjeeDecember 17, 2019
Duchenne Sarepta FDA
Newsletters
FDA Approves Sarepta Duchenne Drug in Stunning Reversal
By Sy MukherjeeDecember 13, 2019
New British Chief Executive Officer of French pharmaceutical group Sanofi Paul Hudson talks to journalists at Sanofi headquarters in Paris on October 1, 2019. (Photo by ERIC PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)
Health
Why Sanofi’s New CEO Is Trading Diabetes Drugs for Cancer Breakthroughs
By James Paton and BloombergDecember 10, 2019
Cancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology
Health
Cancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology
By Riley Griffin, James Paton and BloombergDecember 9, 2019
Paul Hudson, chief executive officer of Sanofi, gestures as he speaks during a panel session on the sidelines of the China International Import Expo (CIIE) in Shanghai, China, on Tuesday, Nov. 5, 2019. The CIIE -- now in its second year -- is designed to showcase the countrys desire to shift its economy toward consumption by buying more foreign goods. Photographer: Qilai Shen/Bloomberg via Getty Images
Finance
Why Sanofi Is Buying a U.S. Cancer Biotech for Nearly 3 Times Its Market Value
By James Paton and BloombergDecember 9, 2019
1...
  • 39
  • 40
  • 41
  • 42
  • 43
...100
Most Popular
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeSeptember 20, 2026
Success
Meet a 71-year-old who retired as a radiologist and professor, and now runs a banana-skewer business: ‘I never want to retire. Why would you do that?’placeholder alt text
By Preston ForeSeptember 20, 2026
Economy
Elon Musk’s DOGE swiped $329 million in humanitarian funding from Nepal, leaving a Gen Z tech revolution to transform the budding country’s economyplaceholder alt text
By Sasha RogelbergSeptember 20, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.